الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 105 |  |  |
| | | from | 105 | | |
Abstract
Hepatocellular carcinoma (HCC) represents a growing public health problem worldwide, with more than 800,000newly diagnosed cases per year. HCC is the most commonly diagnosed primary liver cancer and is estimated to cause over half a million deaths per year worldwide. Most patients are non-surgical candidates and interventional image-guided treatments (IGT) are often the best suitable therapy. Magnetic resonance imaging (MRI) is the most comprehensive and definitive noninvasive modality for evaluating the liver ,MRI provides accurate qualitative and quantitative data. When compared to its main competitor CT, MR has a higher contrast-to-noise ratio (CNR),lack of ionizing radiation exposure and uses contrast agents with the ability to explore both extracellular and hepatocellular compartments. It provides a comprehensive assessment of tissue characteristics through its multiparametric capabilities and advanced techniques such as diffusion. Conventional TACE is used for palliative treatment of unresectable, intermediate stage of hepatocellular carcinoma (HCC), as well as an adjunctive therapy to liver resection, as a bridge to liver transplantation, and before or after radiofrequency ablation. TACE is also used for palliative treatment of unresectable hepatic tumor.